Please assess the completion status of the following clinical trial:

Trial Title: Comparative Atorvastatin Pleiotropic Effects

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Male or female subjects of age of majority to \< 80 years~* Subjects with LDL-C \> 0.5 g/L (1.29 mmol/L) and \< 1.5 g/L (3.87 mmol/L), TG \< 4.00 g/L (4.56 mmol/L) and hs-CRP \>1.5 mg/L and \< 15 mg/L~* Subjects with a documented coronary artery disease.~Exclusion Criteria:~* Female subjects of childbearing potential without contraception~* Subjects with secondary hyperlipidemia~* Diabetic subjects receiving insulin~* Subjects with a contra-indication to statin therapy.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).